The purpose of this study is to assess the potential for a non-invasive sensory based intervention to reduce the stress associated with a COVID-19 diagnosis.
After being informed about the study, participants who provide consent will be randomized to
one of two groups. Participants will receive one of two aromas to inhale with one being
active and the other a control comparison.
Other: Essential Oil Blend
5 drops of on a tester strip
Other: Control Blend
5 drops on a tester strip
Inclusion Criteria:
- Otherwise healthy
- Documented COVID-19 exposure, suspected infection, or diagnosed infection
- Has been tested for or diagnosed with COVID-19
- adults age 18-65 living in the US
- understands and agrees to comply with study procedures
- provides informed consent
Exclusion Criteria:
- Smoker in household
- Pregnant or may become pregnant
- Difficulty breathing
- Pain or pressure in the chest
- Confusion
- Hospitalization
- Asthma, COPD, or other respiratory condition
- demonstrated inability to comply with study procedures
- has participated in an interventional clinical study within 31 days prior to
enrollment
Franklin Health Research Center
Franklin, Tennessee, United States
Investigator: Jessie Hawkins, PhD
Contact: 615-642-1919
j.hawkins@franklinhealth.org
PI
6152613116
info@franklinhealth.org
Jessie Hawkins, PhD, Principal Investigator
Franklin Health Research